Saturday 17 October 2026
Export VEEV’s income statement to Excel — free account
Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
310.30
2.73
−0.87%
Follow VEEV
| Jan '17 | Jan '18 | Jan '19 | Jan '20 | Jan '21 | Jan '22 | Jan '23 | Jan '24 | Jan '25 | Jan '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
73.89 | 62.24 | 68.59 | 71.87 | 112.27 | 84.78 | 54.49 | 63.23 | 52.89 | 36.57 |
Piotroski F-Score |
8 | 7 | 7 | 5 | 5 | 6 | 5 | 5 | 7 | 7 |
Altman Z-Score |
14.99 | 18.45 | 24.93 | 23.43 | 34.16 | 26.31 | 16.76 | 17.84 | 17.18 | 13.57 |
P/S ratio |
10.43 | 12.77 | 18.25 | 19.63 | 29.09 | 19.59 | 12.30 | 14.09 | 13.75 | 10.42 |
Altman Z″-Score (non-manufacturers) |
7.56 | 8.60 | 9.35 | 7.88 | 8.71 | 9.64 | 9.78 | 10.10 | 10.62 | 11.21 |
P/FCF ratio |
42.08 | 39.72 | 52.26 | 50.04 | 78.56 | 48.32 | 34.55 | 37.62 | 35.31 | 24.01 |
P/Operating CF |
(2,751.00) | 6,137.75 | 493.56 | 554.05 | 623.62 | 670.63 | 418.02 | 576.36 | 542.96 | 311.49 |
Beneish M-Score |
(2.75) | (2.59) | (2.51) | (1.69) | (2.47) | (2.83) | (2.64) | (2.63) | (2.59) | (2.63) |
P/B ratio |
8.80 | 9.73 | 12.71 | 13.01 | 18.81 | 12.45 | 7.13 | 7.17 | 6.47 | 4.61 |
Price to Tangible BV |
11.10 | 11.32 | 14.08 | 19.83 | 24.84 | 15.30 | 8.30 | 8.04 | 7.06 | 4.93 |
EV/Sales |
9.49 | 11.67 | 16.98 | 18.64 | 27.96 | 18.30 | 10.86 | 12.38 | 11.87 | 8.36 |
EV/EBITDA |
34.71 | 42.36 | 57.90 | 63.66 | 95.02 | 59.93 | 46.18 | 64.52 | 45.17 | 27.80 |
EV/Operating CF |
36.28 | 34.52 | 47.10 | 47.06 | 74.31 | 44.31 | 29.98 | 32.12 | 29.92 | 18.88 |
EV/FCF |
38.28 | 36.29 | 48.64 | 47.53 | 75.50 | 45.15 | 30.51 | 33.07 | 30.49 | 19.28 |
Quick Ratio |
2.84 | 3.27 | 3.52 | 2.74 | 3.18 | 3.65 | 3.86 | 4.17 | 4.44 | 4.81 |
Current Ratio |
2.88 | 3.31 | 3.57 | 2.78 | 3.23 | 3.70 | 3.94 | 4.24 | 4.51 | 4.89 |
Net Debt/EBITDA |
(3.45) | (4.01) | (4.31) | (3.36) | (3.86) | (4.20) | (6.12) | (8.88) | (7.13) | (6.83) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.68 | 0.64 | 0.60 | 0.56 | 0.55 | 0.54 | 0.50 | 0.44 | 0.41 | 0.39 |
Operating CF/Net income |
1.86 | 1.54 | 1.35 | 1.45 | 1.45 | 1.79 | 1.60 | 1.73 | 1.53 | 1.56 |
Capex/Depreciation |
(0.25) | (0.35) | (0.33) | (0.12) | (0.16) | (0.24) | (0.28) | (1.08) | (0.67) | (0.65) |
| 13.40% | 19.40% | 21.44% | 20.74% | 19.33% | 16.51% | 14.72% | 12.58% | 13.63% | 13.93% | |
| 9.56% | 14.08% | 15.94% | 15.34% | 14.29% | 12.46% | 11.31% | 9.81% | 10.78% | 11.14% | |
ROIC |
56.38% | 68.41% | 94.38% | 30.90% | 39.18% | 58.99% | 46.76% | 43.49% | 63.35% | 87.58% |
Return on Tangible Assets |
15.06% | 19.93% | 21.14% | 29.10% | 23.05% | 18.41% | 16.19% | 13.54% | 14.38% | 14.13% |
Average Days of Receivables |
121.20 | 125.81 | 136.14 | 139.68 | 152.37 | 136.95 | 132.99 | 137.21 | 140.48 | 149.68 |
Research and Development Expense of Revenue |
17.57% | 19.12% | 18.42% | 19.01% | 20.08% | 20.64% | 24.14% | 26.61% | 25.23% | 24.02% |
Selling, General and Administrative Expense of Revenue |
28.96% | 27.40% | 27.29% | 27.59% | 26.22% | 24.83% | 26.28% | 26.57% | 24.12% | 22.83% |
Intangible Assets out of Total Assets |
0.15 | 0.10 | 0.07 | 0.25 | 0.18 | 0.14 | 0.11 | 0.09 | 0.07 | 0.05 |
Share Based Compensation of Revenue |
7.41% | 7.83% | 8.86% | 10.50% | 12.63% | 12.68% | 16.33% | 16.66% | 15.92% | 14.79% |
Graham Net Nets |
0.08 | 0.08 | 0.06 | 0.04 | 0.04 | 0.06 | 0.11 | 0.11 | 0.13 | 0.19 |
Graham Number |
7.87 | 12.12 | 17.52 | 22.74 | 29.20 | 34.54 | 41.04 | 46.21 | 59.79 | 74.26 |
Earnings Yield |
1.35% | 1.61% | 1.46% | 1.39% | 0.89% | 1.18% | 1.84% | 1.58% | 1.89% | 2.73% |
Free Cash Flow Yield |
2.38% | 2.52% | 1.91% | 2.00% | 1.27% | 2.07% | 2.89% | 2.66% | 2.83% | 4.16% |
Revenue per Share |
4.06 | 4.92 | 5.98 | 7.47 | 9.72 | 12.08 | 13.87 | 14.72 | 16.97 | 19.52 |
Operating CF per Share |
1.06 | 1.66 | 2.15 | 2.96 | 3.66 | 4.99 | 5.02 | 5.68 | 6.73 | 8.65 |
Capex per Share |
(0.06) | (0.08) | (0.07) | (0.03) | (0.06) | (0.09) | (0.09) | (0.16) | (0.13) | (0.18) |
Free Cash Flow per Share |
1.01 | 1.58 | 2.09 | 2.93 | 3.60 | 4.90 | 4.94 | 5.51 | 6.61 | 8.47 |
Cash per Share |
3.82 | 5.43 | 7.56 | 7.35 | 11.04 | 15.50 | 19.97 | 25.09 | 31.82 | 40.09 |
Shareholders Equity per Share |
4.81 | 6.46 | 8.58 | 11.27 | 15.04 | 19.00 | 23.92 | 28.93 | 36.03 | 44.08 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.81 | 6.46 | 8.58 | 11.27 | 15.04 | 19.00 | 23.92 | 28.93 | 36.03 | 44.08 |
Free Cash Flow |
136.50 | 222.07 | 301.01 | 433.05 | 542.56 | 750.25 | 766.96 | 885.14 | 1,069.53 | 1,386.09 |
Working Capital |
465.08 | 706.25 | 1,032.39 | 979.95 | 1,594.87 | 2,266.40 | 2,962.51 | 3,824.33 | 4,910.40 | 6,360.57 |
Capital Expenditures |
(7.51) | (11.37) | (9.82) | (4.32) | (8.68) | (14.21) | (13.51) | (26.20) | (20.52) | (29.13) |
Net Current Asset Value |
447.14 | 688.33 | 1,017.40 | 924.94 | 1,531.08 | 2,202.36 | 2,881.27 | 3,737.12 | 4,801.42 | 6,233.04 |
EV/EBIT |
43.30 | 51.02 | 65.69 | 71.91 | 108.42 | 67.01 | 50.97 | 68.17 | 47.16 | 29.16 |
Capex to Sales |
0.01 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
47.59 | 55.85 | 70.59 | 75.71 | 112.83 | 71.71 | 57.72 | 77.55 | 54.61 | 36.32 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.60 | 0.62 | 0.55 | 0.68 | 0.99 | 1.10 | 0.96 | 0.42 | 0.54 | 0.64 |
Cash ROIC |
11.65% | 13.31% | 12.93% | 15.73% | 13.81% | 14.19% | 11.25% | 10.21% | 9.74% | 10.06% |
Accounts Receivable Turnover |
3.36 | 3.28 | 3.08 | 2.97 | 2.83 | 2.83 | 2.91 | 2.82 | 2.82 | 2.70 |
Accounts Payable Turnover |
33.80 | 33.50 | 30.56 | 21.27 | 19.17 | 23.10 | 19.65 | 18.51 | 22.58 | 22.97 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
11.93 | 11.99 | 13.56 | 23.37 | 20.76 | 14.75 | 24.96 | 16.98 | 15.88 | 17.57 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
163.81 | 210.42 | 279.80 | 372.05 | 517.05 | 653.00 | 739.81 | 836.88 | 972.83 | 1,183.73 |
Average Payables |
5.14 | 6.31 | 8.03 | 14.27 | 21.34 | 21.80 | 31.01 | 36.60 | 30.98 | 34.05 |
Average Assets |
811.59 | 1,073.85 | 1,442.05 | 1,962.77 | 2,658.92 | 3,431.27 | 4,310.38 | 5,357.61 | 6,625.34 | 8,159.55 |
Average Common Equity |
578.95 | 779.45 | 1,071.99 | 1,451.67 | 1,965.96 | 2,588.98 | 3,313.94 | 4,180.54 | 5,238.60 | 6,523.56 |
Columns are period end dates